None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 250 patients with mild persistent to moderate asthma (prevalent cases); 2. Age 18-50 yr; 3. Doctors diagnosis of asthma; 4. Asthma severity step 2-3, patients who need inhaled corticosteroids as controller medication (at least 3 months in the past year); 5. PC with internet connection available; 6. Able to communicate in the Dutch language.
Exclusion criteria
Exclusion criteria: 1. Patients with intermittent asthma; 2. Patients with severe asthma; 3. Use of oral glucocorticosteroids as controller medication; 4. Serious co-morbidity interfering with asthma or treatment of asthma; 5. No PC or no internet connection; 6. Not able to communicate in the Dutch language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Asthma related quality of life; 2. Measurement instrument: AQLQ (asthma quality of life questionnaire); 3. Evaluation at baseline, after 3 months and after 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Asthma control; 2. Symptom free days; 3. Exacerbations; 4. Health care utilisation; 5. Absence of work/school; 6. Lung function; 7. Exhaled nitric oxide; 8. Medication use; 9. Side effects. | — |
Contacts
Leiden University Medical Center (LUMC), Department of Medical Decision Making, J-10-87, P.O. Box 9600